Crown Castle Inc. (NYSE: CCI): When MoffettNathanson downgraded the shares to Outperform Weight from Market Perform, it trimmed its $161 target price to $155. The consensus target is $157.78. Thursday’s close was at $132.55.
DiamondRock Hospitality Co. (NYSE: DRH): Though Wells Fargo upgraded the shares to Overweight from Equal Weight, it also trimmed its $10.50 target price to $9. The consensus target is $10.18, and the stock closed at $7.80 on Thursday.
DraftKings Inc. (NASDAQ: DKNG): Oppenheimer reiterated an Outperform rating with a $28 target price. The consensus target is $24.14. Thursday’s close was at $18.91.
Enphase Energy Inc. (NASDAQ: ENPH): Goldman Sachs lowered its $329 target price on the Buy-rated shares to $295, the same as the consensus target. The stock closed on Thursday at $205.27.
Fluence Energy Inc. (NASDAQ: FLNC): Goldman Sachs upgraded the shares to Buy from Neutral. It also bumped its $25 target price up to $29, above the $26 consensus target. Thursday’s $18.64 close was up almost 15% for the day on the upgrade and positive corporate news.
GitLab Inc. (NASDAQ: GTLB): SMBC Nikko initiated coverage with a Neutral rating and a $37 price target. The consensus target is $50.38, and Thursday’s closing print was $33.01.
Global Payments Inc. (NYSE: GPN): Barclays resumed coverage with an Overweight rating and a $125 target. The consensus target is $142.04. The stock closed on Thursday at $103.14.
Globus Medical Inc. (NYSE: GMED): Canaccord Genuity’s upgrade was from Hold to Buy with a $67 target price. The consensus target is $67.17. Thursday’s close at $55.71 was up over 4% on the day.
Holley Inc. (NYSE: HLLY): Canaccord Genuity started coverage with a Buy rating and a $5 target price. The consensus target is $3.91. The stock closed almost 13% higher on Thursday at $2.64 after the upgrade.
Interpublic Group of Companies Inc. (NYSE: IPG): BofA Securities lifted its Neutral rating to Buy, and its $38 target price is now $40. The consensus target is $40.50. The stock closed on Thursday at $36.46.
Juniper Networks Inc. (NYSE: JNPR) Evercore ISI upgraded the stock to Outperform from In Line and lifted the $34 target price to $38. The consensus target is $36.07. The shares closed on Thursday at $34.04.
Neurocrine Biosciences Inc. (NASDAQ: NBIX): Canaccord Genuity upgraded the shares to Buy from Hold. The target price increased from $124 to $132, above the $126.62 consensus target. Thursday’s closing print was $99.21.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
